Homocysteine and familial longevity: The Leiden longevity study

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Wijsman, Carolien A ^a   van Heemst, Diana ^a   Rozing, Maarten P ^a   Slagboom, P Eline ^a,b   Beekman, Marian ^a   de Craen, Anton J M ^a   Maier, Andrea B ^a   Westendorp, Rudi G J ^a   Blom, Henk J ^c   Mooijaart, Simon P ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Netherlands Consortium for Healthy Ageing   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; FOLIC ACID; HOMOCYSTEINE; VITAMIN B GROUP;

ADULT; AGE DISTRIBUTION; AMINO ACID METABOLISM; ARTICLE; CONTROLLED STUDY; FAMILIAL LONGEVITY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERTENSION; LONGEVITY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PROGENY; RISK FACTOR; SIBLING; STROKE; AGED; BLOOD; FAMILY; MIDDLE AGED; NETHERLANDS; PHYSIOLOGY;

ANIMALIA;

AGED, 80 AND OVER; FAMILY; FEMALE; HOMOCYSTEINE; HUMANS; LONGEVITY; MALE; MIDDLE AGED; NETHERLANDS;

EID: 79952382477     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017543     Document Type: Article

References (35)

1. Herskind AM, McGue M, Holm NV, Sorensen TI, Harvald B, et al. (1996) The heritability of human longevity: a population-based study of 2872 Danish twin pairs born 1870-1900. Hum Genet 97: 319-323.
2. Hjelmborg JvB, Iachine I, Skytthe A, Vaupel JW, McGue M, et al. (2006) Genetic influence on human lifespan and longevity. Hum Genet 119: 312-321.
3. Beekman M, Nederstigt C, Suchiman HE, Kremer D, van der BR, et al. (2010) Genome-wide association study (GWAS)-identified disease risk alleles do not compromise human longevity. Proc Natl Acad Sci U S A 107: 18046-18049.
4. Brown-Borg HM, Rakoczy SG, (2005) Glutathione metabolism in long-living Ames dwarf mice. Exp Gerontol 40: 115-120.
5. Uthus EO, Brown-Borg HM, (2006) Methionine flux to transsulfuration is enhanced in the long living Ames dwarf mouse. Mech Ageing Dev 127: 444-450.
6. Almeida OP, McCaul K, Hankey GJ, Norman P, Jamrozik K, et al. (2008) Homocysteine and depression in later life. Arch Gen Psychiatry 65: 1286-1294.
7. Bostom AG, Rosenberg IH, Silbershatz H, Jacques PF, Selhub J, et al. (1999) Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study. Ann Intern Med 131: 352-355.
8. Heijer Mden, Koster T, Blom HJ, Bos GM, Briet E, et al. (1996) Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 334: 759-762.
9. Meurs JBv, Dhonukshe-Rutten RA, Pluijm SM, Klift Mvd, de Jonge R, et al. (2004) Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 350: 2033-2041.
10. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, et al. (1997) Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337: 230-236.
11. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, et al. (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 346: 476-483.
12. Dangour AD, Breeze E, Clarke R, Shetty PS, Uauy R, et al. (2008) Plasma homocysteine, but not folate or vitamin B-12, predicts mortality in older people in the United Kingdom. J Nutr 138: 1121-1128.
13. Vollset SE, Refsum H, Tverdal A, Nygard O, Nordrehaug JE, et al. (2001) Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study. Am J Clin Nutr 74: 130-136.
14. Connolly GM, Cunningham R, McNamee PT, Young IS, Maxwell AP, (2010) Elevated homocysteine is a predictor of all-cause mortality in a prospective cohort of renal transplant recipients. Nephron Clin Pract 114: c5-11.
15. Zhang W, Sun K, Chen J, Liao Y, Qin Q, et al. (2010) High plasma homocysteine levels contribute to the risk of stroke recurrence and all-cause mortality in a large prospective stroke population. Clin Sci (Lond) 118: 187-194.
16. de Ruijter W, de Bree A, Westendorp RG, Assendelft WJ, den Elzen WP, et al. (2009) Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ 338: a3083.
17. Schoenmaker M, de Craen AJ, de Meijer PH, Beekman M, Blauw GJ, et al. (2006) Evidence of genetic enrichment for exceptional survival using a family approach: the Leiden Longevity Study. Eur J Hum Genet 14: 79-84.
18. Westendorp RG, van Heemst D, Rozing MP, Frolich M, Mooijaart SP, et al. (2009) Nonagenarian siblings and their offspring display lower risk of mortality and morbidity than sporadic nonagenarians: The Leiden Longevity Study. J Am Geriatr Soc 57: 1634-1637.
19. Rozing MP, Westendorp RG, de Craen AJ, Frolich M, de Goeij MC, et al. (2010) Favorable glucose tolerance and lower prevalence of metabolic syndrome in offspring without diabetes mellitus of nonagenarian siblings: the Leiden longevity study. J Am Geriatr Soc 58: 564-569.
20. Muntjewerff JW, Hoogendoorn ML, Kahn RS, Sinke RJ, den Heijer M, et al. (2005) Hyperhomocysteinemia, methylenetetrahydrofolate reductase 677TT genotype, and the risk for schizophrenia: a Dutch population based case-control study. Am J Med Genet B Neuropsychiatr Genet 135B: 69-72.
21. Blom HJ, (2000) Genetic determinants of hyperhomocysteinaemia: the roles of cystathionine beta-synthase and 5,10-methylenetetrahydrofolate reductase. Eur J Pediatr 159 (Suppl 3): S208-S212.
22. Nygard O, Refsum H, Ueland PM, Vollset SE, (1998) Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. Am J Clin Nutr 67: 263-270.
23. Selhub J, (2006) The many facets of hyperhomocysteinemia: studies from the Framingham cohorts. J Nutr 136: 1726S-1730S.
24. Rozing MP, Westendorp RG, de Craen AJ, Frolich M, Heijmans BT, et al. (2010) Low serum free triiodothyronine levels mark familial longevity: the Leiden Longevity Study. J Gerontol A Biol Sci Med Sci 65: 365-368.
25. Wijsman CA, Rozing MP, Streefland TC, Le CS, Mooijaart SP, et al. (2011) Familial longevity is marked by enhanced insulin sensitivity. Aging Cell 10: 114-121.
26. Clarke R, Halsey J, Lewington S, Lonn E, Armitage J, et al. (2010) Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med 170: 1622-1631.
27. Marti-Carvajal AJ, Sola I, Lathyris D, Salanti G, (2009) Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev pp. CD006612.
28. Smulders YM, Blom HJ, (2011) The homocysteine controversy. J Inherit Metab Dis 34: 93-99.
29. Lewis SJ, Ebrahim S, Davey SG, (2005) Meta-analysis of MTHFR 677C->T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate? BMJ 331: 1053.
30. Ayyadevara S, Engle MR, Singh SP, Dandapat A, Lichti CF, et al. (2005) Lifespan and stress resistance of Caenorhabditis elegans are increased by expression of glutathione transferases capable of metabolizing the lipid peroxidation product 4-hydroxynonenal. Aging Cell 4: 257-271.
31. Blankenberg S, Rupprecht HJ, Bickel C, Torzewski M, Hafner G, et al. (2003) Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med 349: 1605-1613.
32. Wu G, Fang YZ, Yang S, Lupton JR, Turner ND, (2004) Glutathione metabolism and its implications for health. J Nutr 134: 489-492.
33. Becker A, Henry RM, Kostense PJ, Jakobs C, Teerlink T, et al. (2003) Plasma homocysteine and S-adenosylmethionine in erythrocytes as determinants of carotid intima-media thickness: different effects in diabetic and non-diabetic individuals. The Hoorn Study. Atherosclerosis 169: 323-330.
34. Kerins DM, Koury MJ, Capdevila A, Rana S, Wagner C, (2001) Plasma S-adenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine. Am J Clin Nutr 74: 723-729.
35. Van Hecke MV, Dekker JM, Nijpels G, Teerlink T, Jakobs C, et al. (2008) Homocysteine, S-adenosylmethionine and S-adenosylhomocysteine are associated with retinal microvascular abnormalities: the Hoorn Study. Clin Sci (Lond) 114: 479-487.